Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Invested Capital (2023 - 2025)

Iovance Biotherapeutics has reported Return on Invested Capital over the past 3 years, most recently at 0.57% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.57% for Q4 2025, down 4.0% from a year ago — trailing twelve months through Dec 2025 was 0.57% (down 4.0% YoY), and the annual figure for FY2025 was 0.57%, up 4.0%.
  • Return on Invested Capital for Q4 2025 was 0.57% at Iovance Biotherapeutics, up from 0.59% in the prior quarter.
  • Over the last five years, Return on Invested Capital for IOVA hit a ceiling of 0.53% in Q4 2024 and a floor of 0.73% in Q1 2024.
  • Median Return on Invested Capital over the past 3 years was 0.57% (2025), compared with a mean of 0.6%.
  • Biggest five-year swings in Return on Invested Capital: increased 20bps in 2024 and later decreased -4bps in 2025.
  • Iovance Biotherapeutics' Return on Invested Capital stood at 0.73% in 2023, then rose by 27bps to 0.53% in 2024, then fell by -8bps to 0.57% in 2025.
  • The last three reported values for Return on Invested Capital were 0.57% (Q4 2025), 0.59% (Q3 2025), and 0.56% (Q2 2025) per Business Quant data.